Altimmune CEO to Present at the 2015 Ladenburg Thalmann Healthcare Conference in New York City
(firmenpresse) - GAITHERSBURG, MD -- (Marketwired) -- 09/28/15 -- ., (formerly Vaxin Inc.) a clinical stage immunotherapy and vaccine company, today announced that CEO Bill Enright will present at the 2015 Ladenburg Thalmann Healthcare Conference to be held tomorrow at the Sofitel Hotel in New York City. Enright''s presentation will take place at 11:30am ET.
For information on Ladenburg Thalmann, please visit .
Altimmune is a clinical stage biotechnology company developing next-generation immunotherapeutics and vaccines to address significant public health and biodefense needs. By leveraging specific attributes of its two independent and complementary platform technologies, Altimmune can rapidly design product candidates against a wide range of disease targets, including respiratory diseases, chronic infections, and cancer. Our Densigen™ T-cell platform technology is uniquely suited to direct the immune response against traditionally difficult disease targets, including chronic infections and cancer, by directing an individual''s immune system against multiple target antigens instead of just one. Altimmune''s RespirVec™ platform utilizes convenient needle-free intranasal delivery to achieve broad immunity against disease pathogens more rapidly than conventional vaccines. Altimmune''s product candidates are easily manufactured, highly stable, and provide a safe, effective alternative to current products. .
Bill Enright
President and CEO
Phone: 240-654-1450
Email:
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 28.09.2015 - 06:30 Uhr
Sprache: Deutsch
News-ID 1388276
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
GAITHERSBURG, MD
Phone:
Kategorie:
Commercial & Investment Banking
Anmerkungen:
Diese Pressemitteilung wurde bisher 223 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Altimmune CEO to Present at the 2015 Ladenburg Thalmann Healthcare Conference in New York City
"
steht unter der journalistisch-redaktionellen Verantwortung von
Altimmune (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
